AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer
TAIPEI, April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead compound, Imofinostat (ABT-301), have been selected...
Appotronics' Laser Searchlight Elevates Signature Visuals for National Games Closing Ceremony, Sets Stage for Global Debut at ISE 2026
SHENZHEN, China, Nov. 24, 2025 /PRNewswire/ -- Appotronics (688007.SH), the inventor of ALPD® laser display technology, delivered the pivotal visual technology that defined the closing ceremony of the 15th National Games of China. Held at the...
Tomorrowland 2025: Overcoming Adversity with Unity
SHENZHEN, China, Oct. 17, 2025 /PRNewswire/ -- Tomorrowland is more than just a music festival - it's a global gathering where hundreds of thousands of "People of Tomorrow" return to Boom, Belgium each summer to celebrate electronic music,...